Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10037693HBVENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS10050908HBVENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS10049185HBVENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS30020628HIVENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS20055792HPVENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS44024096HTLV-1ENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TVIS44027810HTLV-1ENSG00000125510.18protein_codingOPRL1NoNo4987P41146
TCGA Plot Options
Drug Information
GeneOPRL1
DrugBank IDDB00921
Drug NameBuprenorphine
Target IDBE0002378
UniProt IDP41146
Regulation Type
PubMed IDs10998549; 14614092
CitationsBloms-Funke P, Gillen C, Schuettler AJ, Wnendt S: Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor. Peptides. 2000 Jul;21(7):1141-6.@@Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ: Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12;23(32):10331-7.
GroupsApproved; Illicit; Investigational; Vet_approved
Direct ClassificationPhenanthrenes and derivatives
SMILESCO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4
PathwaysBuprenorphine Action Pathway
PharmGKBPA448685
ChEMBLCHEMBL560511